Form 4: Innoviva Inc. Insider Trading: Zhen Acquires Shares

Innoviva Inc. Chief Accounting Officer Marianne Zhen acquired 12,766 shares of common stock and was granted stock options.

Summary

• Marianne Zhen, Chief Accounting Officer of Innoviva, Inc., acquired 12,766 shares of common stock on May 4, 2026.
• Zhen also received a grant of non-statutory stock options with an exercise price of $22.99.
• The acquisition and grant were conditional upon stockholder approval of the Issuer's 2026 Equity Incentive Plan.
• Vesting for both the restricted stock units (RSUs) and options begins on February 20, 2027, with subsequent installments over three months.
• Accelerated vesting provisions exist for both options and RSUs in the event of a change in control or involuntary termination following a change in control.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it details standard insider compensation and stock acquisition, indicating executive commitment, but without immediate financial impact or significant new strategic information.

Positives

• Insider acquisition of shares by a key executive can signal confidence in the company's future prospects.
• Grant of stock options indicates a long-term incentive structure aligned with executive performance and shareholder value.
• Conditional grant structure tied to stockholder approval of an equity incentive plan suggests a commitment to good corporate governance.

Negatives

• The filing details a grant of options rather than an outright purchase by the executive, which may have different implications for immediate capital commitment.
• The exact value of the stock options is not immediately realized until vesting and exercise, and is subject to market fluctuations.

Risks

• Vesting of RSUs and options is contingent on continuous service, meaning departure from the company before vesting dates will result in forfeiture.
• The value of the stock options is subject to the company's stock performance and the exercise price of $22.99.
• Potential for accelerated vesting in the event of a change in control or involuntary termination could lead to significant payouts for the executive under specific circumstances.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance. However, the grant of stock options and RSUs with vesting schedules extending into the future implies management's expectation of continued company performance and value creation.

Management Comments

• The Reporting Person was conditionally granted time-vested restricted stock units ("RSUs") and non-statutory stock options ("Options").
• The RSUs and Options were granted subject to stockholder approval of the Issuer's 2026 Equity Incentive Plan at the Issuer's 2026 annual meeting of stockholders on May 4, 2026.
• Twenty-five percent of each of the RSUs and Options vest on February 20, 2027 and the balance will vest in twelve (12) substantially equal installments thereafter on each three (3) month anniversary of the initial vesting date, in each case, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
• Accelerated vesting provisions are in place for Options and RSUs in the event of a "change in control" or "involuntary termination" following a "change in control" under specific conditions.

Industry Context

StockSavvy.ai notes that the issuance of equity-based compensation, such as RSUs and stock options, is a standard practice in the biotechnology and pharmaceutical sectors, like Innoviva, Inc., to attract, retain, and incentivize key executive talent by aligning their interests with long-term shareholder value.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of equity awards aligns executive incentives with long-term shareholder value creation, subject to the company's performance.
• Employees: The filing pertains to a specific executive's compensation and does not directly impact other employees, though the equity plan may be a template for others.
• Management: Marianne Zhen benefits from the stock acquisition and option grant, with vesting tied to continued service and company performance.

Next Steps

• Stockholder approval of the Issuer's 2026 Equity Incentive Plan.
• Continuous service by Marianne Zhen through applicable vesting dates.
• Potential vesting acceleration upon change in control or involuntary termination.

Key Dates

Keywords

Innoviva Inc., INVA, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Beneficial Ownership, Securities Exchange Act, Equity Incentive Plan, Marianne Zhen, Chief Accounting Officer